Noul Co (XKRX:376930) Change In Receivables : ₩0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Noul Co Change In Receivables?

Noul Co's change in receivables for the quarter that ended in Mar. 2024 was ₩0 Mil. It means Noul Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Noul Co's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-824 Mil. It means Noul Co's Accounts Receivable increased by ₩824 Mil from Dec. 2022 to Dec. 2023 .

Noul Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩561 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Noul Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 1,768.92.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Noul Co's liquidation value for the three months ended in Mar. 2024 was ₩3,866 Mil.

Noul Co Change In Receivables Historical Data

The historical data trend for Noul Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noul Co Change In Receivables Chart

Noul Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

28.41

-180.54

-211.57

-226.44

-823.68

Noul Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial										-	-	-	-	-

Noul Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Noul Co (XKRX:376930) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Noul Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	560.704	/	28.924	*	91
=	1,768.92

2. In Ben Graham's calculation of liquidation value, Noul Co's accounts receivable are only considered to be worth 75% of book value:

Noul Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	14402.391	-	12706.718	+	0.75 * 560.704	+	0.5 * 3499.653
=	3,866

Noul Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Noul Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Noul Co (XKRX:376930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

B-10F, 338, Gwanggyojungang-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16942

Website

https://www.noul.kr

Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.

Noul Co (XKRX:376930) Headlines

No Headlines